This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

SAN FRANCISCO (KGO) -- We've told you all about the DOGE cuts and now, some concerning news for an HIV survivor in San Francisco. Not only did the Social Security Office tell him that his ...

However, even this LRA combination needs improvement as it is inefficient at activating proviruses in cells of people living with HIV (PLWH). We performed a CRISPR screen in conjunction with AZD5582 & ...

MatCH, which provides HIV and TB services in three provinces, told almost 900 employees it would not be able to pay their salaries after receiving a stop-work notice from USAID. The employees obtained ...

The Trump administration plans to remove all the members of a presidential advisory council on HIV/AIDS and provided no timeline for replacing them as the government overhauls its prevention and ...

CRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...

CRISPR–Cas, a bacterial defence system that recognizes and slashes specific sequences in viral genomes, gave scientists the power to delete or edit genes with remarkable precision. Developed in ...

"If HIV could talk, it would say 'thank God for the US president, because I can now spread more easily. I love the Trump administration'," says HIV activist Mitchell Warren, who's the executive ...

“If HIV could talk, it would say ‘thank God for the US president, because I can now spread more easily. I love the Trump administration’,” says HIV activist Mitchell Warren, who is the ...

This article was featured in One Great Story, New York’s reading recommendation newsletter. Sign up here to get it nightly. In the late 1980s and early 1990s, the giant Tower Records on 66th ...